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ABSTRACT
Diff  erent kinds of physical therapy are used in medical rehabilitation of neuro-
logical patients with motor defi  ciency: partial body weight-supported treadmill 
training, driven gait orthosis, neuromuscular electrical stimulation and neuro-
orthopaedic suit therapies. Neuro-orthopaedic pneumosuit (NOPS) Atlant 
(Dynaforce, Russia) creates a muscle framework by dynamic proprioceptive 
stimulation, stabilizing the trunk and the extremities, reducing pathological 
synergies and normalizing patient’s motor activity. Th   e aim of the present study 
was to investigate the infl  uence of 3-month therapy using the NOPS Atlant on 
gait characteristics in preschool children with spastic form of cerebral palsy 
(CP). Six CP children with spasticity of lower extremities with (mean±SE) 
age of 5.2±0.8 years participated in the present study. Children had NOPS 
Atlant therapy sessions during three months, supervised by an experienced 
physiotherapist. Th   e kinematic and kinetic characteristics of gait were measured 
using 3-D movement analysis system Elite Clinic (BTS S.p.A., Italy). Aft  er 
3-month therapy using the NOPS Atlant, signifi  cant increase (7.9%) of the 
stride length of gait was found as compared with the initial data. Children with 
spastic CP demonstrated signifi  cant improvement of range of motion of hip 
joint abduction, decrease of knee joint external rotation, as well as positive 
changes in foot progression angle during gait. In conclusion, motor function 
re-activation during gait in preschool children with spasticity caused by cerebral 
palsy was noted aft  er 3-month therapy using the NOPS Atlant. However, future 
research is needed to elucidate mechanisms of neurodynamic therapy eff  ect on 
motor ability in children with CP.
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INTRODUCTION 
Cerebral paralysis (CP) causes numerous impairments of neuromuscular and 
skeletal systems like spasticity, dystonia, joint contractures, abnormal bone 
growth, body balance and selective motor control impairments [9]. CP is a fre-
quent cause of motor impairments in childhood, it occurs in 2–3 children per 
1000 livebirths [21]. Most frequent motor impairment in CP children is spas-
ticity [6], which is characterised by increase of velocity-dependent tonic refl  ex 
accompanied by overnormal stretch-refl  ex and produced by hyperirritability 
of stretch-refl  ex due to higher motor neuron syndrome [14]. A recent study 
on Australian population-based CP register identifi  ed 2956 individuals (1658 
males, 1298 females, born in 1970–2003) with spastic CP [17]. Th  e  results 
showed that among individuals born <32 weeks, 48% had diplegia, whereas for 
children born ≥32 weeks the respective number was 24%. An increased propor-
tion of spastic diplegia in relation to quadriplegia and wide variations across 
studies in the proportion of diplegia (range 34–90%) and bilateral spastic CP 
(range 51–86%) were revealed. 
Children with hemiparesis began to walk at the age of 18–21 months, 
75–85% of children with spastic diplegia walked at the age of 4 years, but only 
10% of children with spastic tetraparesis walked at the age of 7 years [22]. 
Despite the fact that a signifi  cant part of children have good cognitive abilities 
and have independent social life, numerous children remain dependent on 
additional motion devices such as rulators or crutches [1]. Study of Harvey 
et al. [10] found that children at Level III according to Gross Motor Func-
tion Classifi  cation System (GMFCS) who had undergone multilevel surgery, 
showed more changes in mobility as compared with children at Level I/II at 
home and in school activities. Wheelchairs were most commonly used in the 
community before and aft  er single-event multijoint surgery.
Diff  erent modalities of physical therapy are used in medical rehabilitation 
of neurological patients with motor defi  ciency: partial body weight-supported 
treadmill training [4, 16], driven gait orthosis [3], neuromuscular electrical stim-
ulation [12] and neuro-orthopaedic suit therapies [2, 8, 19]. Neuro-orthopaedic 
pneumosuit (NOPS) Atlant (Dynaforce, Russia) creates a muscle framework 
by dynamic proprioceptive stimulation stabilizing the trunk and the extremi-
ties, reducing pathological synergies and normalizing patient’s motor activity. 
Previously, the eff  ect of the NOPS Atlant has been studied in adult patients with 
diff  erent neurologic or orthopaedic pathologies [13]. To our knowledge, the 
present research includes data of the fi  rst study where NOPS Atlant has been used 
in physical therapy for children with CP, aged 3–7 years. Th   e aim of the present 
study was to investigate the infl  uence of 3-month therapy using the NOPS Atlant 
on gait characteristics in preschool children with spastic CP.100  |  H. Gapeyeva, P. Mitt, J. Ereline, M. Pääsuke
MATERIALS AND METHODS
Subjects 
Six CP children (fi  ve girls and one boy, GMFCS level II–III) with spasticity of 
lower extremities aged 3–7 years participated in the present study before and 
3 months aft  er therapy using the NOPS Atlant (Table 1). 
Table 1. Anthropometric data of subjects (mean ±SE)
Characteristics Before therapy After therapy
Age (year) 5.20±0.80 5.40±0.75
Body mass (kg) 20.70±2.110 21.76±2.410
Body height (m) 1.13±0.04 1.15±0.04
Body mass index (kg/m2) 15.90±0.650 16.24±0.860
Lower extremity length (m), R 0.58±0.03 0.59±0.03
Lower extremity length (m), L 0.58±0.03 0.59±0.03
Note: R – right, L – left; p>0.05 
All participants were recruited from one nursery school of Tartu, Estonia. 
Organizers of the study excluded the recruitment of children with severe speech 
and language disorders or problems in their mental or physical development. 
Inclusion criteria were: spastic diplegia syndrome, ability to walk at least 20 m 
with or without additional devices, absence of epileptic cramps, good cognitive 
ability, and absence of Botox injections during the recent 3 months. 
Th   e study carried the approval of the Ethics Committ  ee of the University of 
Tartu. A writt  en informed consent from the children’s parents and each child’s 
assent were obtained for participation in the present study. 
Measurements were performed partly in the nursery school and partly at the 
Laboratory of Kinesiology and Biomechanics, University of Tartu. All assess-
ments were carried out in the mornings to minimize the possibility of fatigue. All 
tests were performed individually, by appropriately qualifi  ed therapists, who were 
unaware of the children’s group assignment. Th   e subjects were given instructions 
before data collection and the testing procedures were demonstrated, followed 
by practice session to familiarize the subjects with the procedures. 
Intervention 
Th   e children received physical therapy and exercise therapy using the NOPS 
Atlant (Figures 1A and 1B) during the period of three months in nursery   Influence of 3-month therapy using the neuro-othopaedic suit Atlant ...  |  101
school, supervised by an experienced physiotherapy specialist. Suits have been 
used in accordance with height and chest dimensions of each child individually.
B  A  C 
Figure 1. Neuro-orthopaedic pneumosuit Atlant – anterior (A) and posterior (B) view 
and biomechanic model of trunk and lower extremities (C). 
Th   e mean (±SE) number of therapy sessions using the NOPS Atlant was 
12.2±1.9 during the treatment period, and each session increased progressively 
from 10 min at the beginning of therapy to 35 min at the end of the therapy 
period. Th   erapy sessions using the NOPS Atlant were planned individually and 
aimed at improving body balance, the symmetry of movements and posture, 
as well as increasing muscle strength, infl  uencing muscle tone and gait patt  ern 
improvement.  
Methods 
Th   e kinematic characteristics of gait were measured using 3-dimensional move-
ment analysis system Elite Clinic (BTS S.p.A., Italy). Twenty passive refl  ecting 
markers were att  ached to the selected points of the body according to the Helen 
Hayes protocol using the Davis biomechanical model [5] (Figure 1C). Gait 
temporal (stance time, swing time, double support time, stride time, cadence) 
and distance characteristics (step length, stride length, step width, velocity for 
each leg, mean velocity) as well as range of motion (ROM) of hip, knee and 
ankle joints were calculated. Th   ree to six trials of gait with comfortable velocity 
for each child were recorded and the best trial was taken for analysis [7]. All 
studies were performed in same time of day (from 10 to 12 a.m.).102  |  H. Gapeyeva, P. Mitt, J. Ereline, M. Pääsuke
Statistical analysis
Data are means and standard error of mean (SE). Student’s paired t-test was 
used to fi  nd diff  erences of data before and aft  er 3-month NOPS therapy. A level 
of p<0.05 was selected to indicate statistical signifi  cance. 
RESULTS 
No signifi  cant diff  erences in subjects’ anthropometric data as compared before 
therapy and aft  er three months were observed (Table 1). Aft  er 3-month ther-
apy using the NOPS Atlant the temporal characteristics of gait did not diff  er 
signifi  cantly (p>0.05) as compared with the pre-therapy period (Table 2). A 
signifi  cant (p<0.05) increase (7.91%) of the stride length of gait was found as 
compared with the initial data (Table 3). Decline of diff  erence in gait velocity 
between right and left   leg was noted – from 5.10% before therapy to 0.98% 
aft  er 3-month NOPS Atlant therapy.
Table 2. Temporal characteristics of gait (mean ±SE)
Characteristics Before therapy After 3-month therapy
Stance time (%), R 60.98±1.590 61.26±0.850
Stance time (%), L 59.10±1.470 57.96±0.860
Swing time (%), R 39.02±1.590 39.02±1.590
Swing time (%), L 40.90±1.470 42.04±0.860
Double support time (%), R 10.34±1.040 11.02±1.050
Double support time (%), L 9.44±1.36 9.46±0.66
Cadence (step/min) 137.74±10.370 148.52±13.340
Note: data are % of gait cycle; R – right, L – left; p>0.05 
Table 3. Distance characteristics of gait (mean ±SE)
Characteristics Before therapy After 3-month therapy
Step length (m), R 0.39±0.04 0.42±0.04
Step length (m), L 0.98±0.14 1.02±0.15
Velocity (m/s), R 0.93±0.13 1.03±0.15
Velocity (m/s), L 0.98±0.14 1.02±0.15
Stride length (m), R 0.75±0.06 00.82±0.07*
Stride length (m), L 0.76±0.07 00.82±0.07*
Step width (m), R 0.10±0.01 0.10±0.01
Step width (m), L 0.10±0.01 0.09±0.01
Note: R–right, L–left; *p<0.05 as compared before therapy  Influence of 3-month therapy using the neuro-othopaedic suit Atlant ...  |  103
-15
-12
-9
-6
-3
0
3
6
9
12
15
H1 H2 H3 H1 H2 H3
H
i
p
 
A
b
d
-
A
d
d
 
R
O
M
 
(
°
)
-15
-12
-9
-6
-3
0
3
6
9
12
15
K1 K2 K3 K1 K2 K3
K
n
e
e
 
R
o
t
a
t
i
o
n
 
R
O
M
 
(
°
)
-15
-12
-9
-6
-3
0
3
6
9
12
15
F1 F2 F3 F1 F2 F3
F
o
o
t
 
 
P
r
o
g
r
e
s
s
i
o
n
 
A
n
g
l
e
 
(
°
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Right                                                       Left 
Before therapy 
After therapy 
*
*
Right                                                       Left 
*
*
*
Right                                                       Left 
A 
B 
C 
Figure 2. Hip abduction-adduction ROM (A), knee joint rotation ROM (B) and foot 
progression angle (C) during gait before and after 3-month neuro-orthopaedic 
pneumosuit Atlant therapy in children with spastic CP (mean±SE). 1 – initial contact 
of the foot with the ground, 2- maximal angle in stance, 3 – maximal angle in swing; 
* p<0.05. 104  |  H. Gapeyeva, P. Mitt, J. Ereline, M. Pääsuke
Signifi  cant increase (p<0.05) of right hip abduction ROM (Figure 2A) and 
knee joint external rotation ROM (Figure 2B) in swing phase as well as increase 
of foot progression angle (Figure 2C) in stance phase during gait were noted 
aft  er 3-month NOPS therapy as compared to the pre-therapy period. 
No signifi  cant diff  erences emerged in kinematic characteristics of other 
joints between pre- and post-therapy period.
DISCUSSION 
Th   e main results of the 3-month application of the NOPS Atlant in preschool 
children with moderate level of CP were: (1) children demonstrated signifi  cant 
improvement of ROM of hip abduction and knee external rotation as well as 
increase of foot progression angle, and (2) stride length of gait was increased 
as compared to the initial data.
Th   e qualitative classifi  cations of gait in children with spastic diplegia have 
been more widely used and diff  erent classifi  cations have been applied for this 
aim. Main concerns have appeared about the validity of classifi  cations, which 
are not based on quantitative data [18]. Th   e results of the present study are 
based on standard gait instrumental kinematic analysis and improvement of 
gait characteristics have been found in preschool children with CP aft  er using 
NOPS Atlant. In the study of Bailes et al. [2] the infl  uence of 3-week Th  eraSuit™ 
method on gait in two children with spastic diplegia syndrome was analysed. 
Th   e patients performed trainings fi  ve days a week and the duration of the one 
training was 3–4 hours. Aft  er training, improvement of gait characteristics 
(speed and cadence, movement patt  ern) and of posture was noted. Sologubov 
[20] investigated a 20-day orthopaedic suit therapy that was performed using 
Adeli-92 load suit in children with spastic diplegia syndrome aged 10 to 18 
years; each session lasted for one hour. Aft  er Adeli suit therapy the improve-
ment of postural steadiness and increase of ROM and length of step during 
gait were noted. Other studies [8, 19] demonstrated decrease of stride width 
during gait and toe-off   phase duration and increase of swing phase duration 
in children with spastic diplegia aged 6 to 10 years aft  er three-week treatment 
using Adeli suit. Th   e present study diff  ered from research mentioned above by 
its longer duration and younger age of children as well less intensive therapy. 
Another study compared the eff  ect of the conventional therapy program and 
modifi  ed (individualized) therapy with Adeli suit in 36 CP children [15]. It was 
found that in case of modifi  ed therapy where the child was guided to use more 
functional and primary-task movements and exercises, the treatment eff  ect was 
bett  er as compared with the conventional therapy programme.  Influence of 3-month therapy using the neuro-othopaedic suit Atlant ...  |  105
A special physical therapy programme using the NOPS Atlant has been 
elaborated for children with a more enhanced level of CP in Kazan University 
of Medicine by Isanova [11] but the proposed programme could not be used 
in the studied group of preschool children with moderate-level CP. Th  erapy 
using the NOPS Atlant is based on individual tasks. Th   is aspect supports the 
study of van den Broeck et al. [21], where gait and mobility in 3-10 year-old 
children was analysed. Th   e authors found that individual training programme 
is most eff  ective for improvement of spastic muscle function and gait charac-
teristics [21]. 
One factor infl  uencing the results of the study could be a number of therapy 
sessions per week. According to Isanova’s results [11], maximum eff  ect of the 
therapy with the NOPS Atlant is att  ained in case it is applied for three times 
per week and additionally in home environment. In the present study it was 
not possible to give Atlant suits for home use because the parents had not 
performed a course of therapy rules. 
Th   e present study had some limitations. Th   e number of subjects was small, 
due to having to consider numerous criteria for including the subjects in the 
study. On the other hand, it decreased the homogeneity of the studied group. 
Th   e therapy process was planned during a 3-month period with children par-
ticipating twice a week, however, diseases or other reasons caused frequent 
absence of children from therapy lessons. Th   e total time for physical therapy 
lesson was 40 minutes and the time of wearing the NOPS Atlant increased 
gradually in accordance with methodology, but we did not compare data with 
groups of CP children with lower limb spasticity who did not receive NOPS 
Atlant therapy. 
In summary, children with spastic CP demonstrated signifi  cant improve-
ment of range of motion of hip joint abduction, decrease of knee joint external 
rotation, as well as changes in foot progression angle during gait. Motor func-
tion re-activation during gait (lengthening of stride) in preschool children with 
spasticity caused by cerebral palsy was noted aft  er 3-month therapy using the 
NOPS Atlant. However, future research is needed to elucidate mechanisms of 
neurodynamic therapy eff  ect on motor ability in children with CP.
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